SOLLINI, MARTINA
 Distribuzione geografica
Continente #
AS - Asia 1.895
NA - Nord America 983
EU - Europa 809
SA - Sud America 365
AF - Africa 54
OC - Oceania 23
Totale 4.129
Nazione #
US - Stati Uniti d'America 913
SG - Singapore 851
CN - Cina 560
IT - Italia 395
BR - Brasile 319
HK - Hong Kong 280
RU - Federazione Russa 85
DE - Germania 78
VN - Vietnam 56
NL - Olanda 54
GB - Regno Unito 53
FI - Finlandia 50
CA - Canada 33
IN - India 33
MX - Messico 31
AT - Austria 21
AU - Australia 21
AR - Argentina 20
JP - Giappone 19
MA - Marocco 19
PL - Polonia 18
TR - Turchia 14
ZA - Sudafrica 14
ES - Italia 12
LT - Lituania 11
PK - Pakistan 11
TH - Thailandia 11
EG - Egitto 8
SE - Svezia 8
BD - Bangladesh 7
ID - Indonesia 7
IQ - Iraq 7
EC - Ecuador 6
FR - Francia 6
PY - Paraguay 6
DZ - Algeria 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CO - Colombia 4
IL - Israele 4
KR - Corea 4
VE - Venezuela 4
BA - Bosnia-Erzegovina 3
KE - Kenya 3
MY - Malesia 3
OM - Oman 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
CL - Cile 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UA - Ucraina 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SN - Senegal 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 4.129
Città #
Singapore 448
Hong Kong 276
Dallas 164
Ashburn 149
Shanghai 135
Beijing 125
Milan 117
Hefei 104
New York 64
Los Angeles 44
Rome 30
Seattle 30
Moscow 29
Boardman 27
São Paulo 25
Helsinki 24
Nuremberg 21
Amsterdam 18
Chennai 17
Ho Chi Minh City 17
Turku 17
Council Bluffs 16
London 16
Munich 16
Washington 16
Brooklyn 14
Canberra 14
Mexico City 14
Santa Clara 14
Denver 13
Montreal 13
Warsaw 13
Cesano Boscone 12
Tokyo 12
Hanoi 11
Johannesburg 11
Rio de Janeiro 11
Bang Kruai 10
Brescia 10
Florence 10
Houston 10
Poplar 10
Ankara 9
Atlanta 9
Lappeenranta 9
Belo Horizonte 8
Phoenix 8
Falkenstein 7
Manchester 7
Rabat 7
Sydney 7
Toronto 7
Vienna 7
Assago 6
Bologna 6
Curitiba 6
Hangzhou 6
Pisa 6
Bari 5
Charlotte 5
Chicago 5
City of London 5
Guangzhou 5
Lahore 5
Querétaro 5
Salvador 5
Secaucus 5
Shenzhen 5
Turin 5
Vancouver 5
Brasília 4
Carapicuíba 4
Contagem 4
Córdoba 4
Frankfurt am Main 4
Giza 4
Guarulhos 4
Itabuna 4
Jiaxing 4
Macerata 4
Motta Sant'Anastasia 4
Mumbai 4
Naples 4
Orem 4
Ribeirão Preto 4
Riyadh 4
San Francisco 4
Sham Shui Po 4
St Louis 4
Stockholm 4
Aracaju 3
Asunción 3
Bengaluru 3
Biên Hòa 3
Boston 3
Canoas 3
Casablanca 3
Catania 3
Cesena 3
Changsha 3
Totale 2.432
Nome #
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 128
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 91
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 87
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 77
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 74
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 72
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 71
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 70
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 70
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 69
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 69
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 69
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 68
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 68
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 66
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 62
Cardiac molecular pathways influenced by doxorubicin treatment in mice 62
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 62
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 61
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 61
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 60
Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET 60
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 60
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 59
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions 57
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 54
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 52
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 49
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 49
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 48
Alternative Nuclear Imaging Tools for Infection Imaging 48
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 47
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 46
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 46
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis 45
FAP expression in alpha cells of Langherhans insulae-implications for FAPI radiopharmaceuticals' use 45
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 43
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 43
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 43
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 43
On the Automation of Radiomics-based Identification and Characterization of NSCLC 42
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 42
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 42
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 42
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 42
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 40
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 39
Radiomics of Liver Metastases: A Systematic Review 39
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 38
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 38
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 38
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 38
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 37
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 37
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 36
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 36
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 36
Radiomics of Biliary Tumors: A Systematic Review of Current Evidence 35
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 35
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 35
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 35
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging 35
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 35
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges 34
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact 34
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 33
PET/CT radiomics in breast cancer: Mind the step 33
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 33
Perceived risk and decision-making: navigating uncertainty in clinical practice 32
Reply to: "Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings" 32
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model 32
Methodological framework for radiomics applications in Hodgkin’s lymphoma 31
Methodological Aspects of Lymphoscintigraphy: Bicompartmental Versus Monocompartmental Radiocolloid Administration 31
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 31
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 31
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 31
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 30
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer 30
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 30
Mapping Tumor Heterogeneity via Local Entropy Assessment: Making Biomarkers Visible 30
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 30
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 30
Patients' findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT 29
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 29
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 28
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 28
The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification 28
From pixels to predictions: the scrying power of molecular imaging 27
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 27
Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance 27
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 27
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach 27
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome 27
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 26
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 26
Dual adversarial deconfounding autoencoder for joint batch-effects removal from multi-center and multi-scanner radiomics data 26
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 25
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers 24
Molecular guidance for planning external beam radiation therapy in oncology 22
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [18F]FDG PET: Preliminary Results from a Prospective Cohort 19
Totale 4.396
Categoria #
all - tutte 27.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023138 6 0 1 0 0 1 0 0 2 10 116 2
2023/2024717 8 145 82 45 56 69 33 85 41 35 31 87
2024/20251.548 157 53 21 59 80 143 177 158 305 194 114 87
2025/20262.022 382 352 198 620 449 21 0 0 0 0 0 0
Totale 4.426